CAR-T therapy safety check: researchers track Long-Term effects in 178 patients
NCT ID NCT07474051
First seen Mar 22, 2026 · Last updated Jun 18, 2026 · Updated 11 times
Summary
This study follows about 178 people who previously received AvenCell's CAR-T cell therapy for blood cancers or prostate cancer. The goal is to monitor long-term safety, including delayed side effects like new cancers or autoimmune problems. Participants are not receiving new treatment but are being observed to better understand the therapy's lasting effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Charité Universitätsmedizin Berlin
Berlin, Germany
-
Klinikum der Universität (LMU) Muenchen
Munich, Germany
-
Technische Universitaet Dresden - Universitaetsklinikum Carl Gustav Carus
Dresden, Germany
-
Universitatsklinikum Ulm
Ulm, Germany
-
Universitätsklinikum Marburg
Marburg, Germany
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.